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Summary Quantitative microdensitometry and computerised interactive image analysis were used to compare
the expression of endogenous lectins by cells of mouse colon 26 carcinomas, growing either as primary
tumours or metastases, in five different anatomic sites (caecum, liver, lung, spleen, s.c.). Endogenous lectins
were visualised in tissue sections using the ABC peroxidase technique with a panel of 17 biotinylated
neoglycoproteins representing a variety of carbohydrates found in glycoproteins, glycolipids and proteo-
glycans. Clear-cut site-associated differences in endogenous lectin expression were detected in cancer cells
growing in all five sites. The patterns of these changes were complex and shifts in expression of different lectins
were independently variable in both direction and amount. In addition to site-associated variations, differences
in lectin expression were also detected in the liver and lungs, between cells in spontaneous metastases and cells
in colonies generated by direct injection of cancer cells into the bloodstream. The results demonstrate
quantitative, as distinct from qualitative, differences developing in cancer cell populations after delivery of cells
to different target organs. The differences between liver and lung metastases are in accord with analogous
site-associated differences in metastatic patterns produced by colon carcinoma cells in mice and in humans.
Metastasis of metastases constitutes an important aspect of
disseminative patterns in human colorectal carcinoma (Weiss,
1985a; Weiss et al., 1986). Autopsies on cases with a history
of adenocarcinoma of the upper rectum indicated that hema-
togenous metastases developed first in the liver after seeding
via the portal venous system; next, lung metastases were
generated mainly by the liver metastases and next, arterial
metastases were generated mainly by the lung metastases. In
histologically similar cancers of the lower rectum, hemato-
genous metastases developed first in the lungs following
seeding via the systemic veins and next, arterial metastases
were generated mainly from the lung lesions. However, the
patterns of arterial metastases seen in the two groups were
different (Weiss et al., 1981), and it was considered that one
underlying cause of this difference was associated with the
metastatic growth of the first group in the liver, prior to
dissemination to the lungs.
In accord with the human autopsy data, the patterns of
metastasis and organ colonisation in mice were also different
following intravascular injection of colon-26 (Co26) carcin-
oma cells which had previously been grown in the liver, lungs
or liver-then-lungs (Weiss & Ward, 1988).
In the present experiments, we have attempted directly to
document growth-site associated changes in cancer cell popu-
lations by modelling certain aspects of hematogenous meta-
stasis of human colorectal carcinoma, with Co26 growing in
relevant sites in mice, namely: caecum ('primary' site), liver
(secondary, metastatic site), lungs (tertiary, metastatic site),
and the subcutis and spleen (quaternary, arterial metastatic
sites). As a parameter of site-associated changes, we have
examined the distribution of Co26 cancer cells populations
within tumours in these different sites with respect to endo-
genous lectin expression.
In the present context, endogenous lectins are operation-
ally defined as tissue constituents with different affinities for
diverse carbohydrates. Endogenous lectins were identified
histochemically by means of ABC-peroxidase reactions using
a panel of biotinylated neoglycoproteins and these reactions
were quantitated by means of microdensitometry and image-
analysis. Neoglycoproteins were selected with carbohydrate
residues representing those in naturally occurring peripheral
sugar residues of both glycoproteins and glycolipids, and
peripheral or internal sugars common to glycoproteins or
proteoglycans.
Materials and methods
Experimental details given by Glaves et al. (1989) and Vidal-
Vanaclocha et al. (1990) are described here in outline only.
Animals and tumours
Balb/c 6 to 8 week old female mice (West Seneca Labs, NY)
were used throughout. The Co26 carcinoma, originally induc-
ed by N-methyl-N-nitrosourethane (CorBett et al., 1975), was
maintained by serial subcutaneous passage of mechanically-
dissociated cells. Tumours were generated in five anatomic
sites using cells mechanically-dissociated from subcutaneous
(s.c.) tumours. Caecal tumours were obtained 12 days follow-
ing injection of 106 cells into the apical lymphoid follicle as
described elsewhere (Mayhew et al., 1987). Spleen tumours
were obtained 9 days after intrasplenic injection of 103-104
cells (Mayhew et al., 1987) and s.c. tumours were obtained 18
days after injections of 1Os cells. Liver 'metastases' were
generated in mice given intrasplenic injections which then
underwent splenectomy 7 days post-injection; the lesions
were obtained 13 days after splenectomy. Liver 'colonies'
were obtained 14 days following injection of 10 Co26 cells
into the portal vein. Lung 'metastases' were generated from
mice with tumours growing in the kidney following direct
renal injection of I04 cells, followed by nephrectomy 9 days
later; lung lesions were obtained 13 days after nephrectomy.
Lung 'colonies' were obtained 14 days following injection of
iOs cells into a lateral tail vein.
Histochemistry
Tumour tissue from each site was fixed in 95% ethanol at
4°C and wax-embedded at low temperature (Saint-Marie,
1962). Sections were cut at 5 itm and following rehydration,
endogenous lectins were identified by a modification of the
ABC peroxidase method using a panel of 17 carbohydrates
which were either directly biotinylated or coupled to biotiny-
lated bovine serum albumin neoglycoproteins (Glaves et al.,
1989). The panel of neoglycoprotein (NGP) probes and their
carbohydrate specificities are listed in Table I. Sites of re-
action of endogenous lectins with these probes were visual-
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Table I Neoglycoproteins used in histochemical peroxidase re-
actions
Neoglycoproteins Nominal carbohydrate specificity
Group I
N-acetyl-D-glucosamine-BSA
(GlcNAc) N-acetylated sugars
N-acetyl-D-galactosamine-BSA
(GalNAc)
Gal-PI, 3-galNAc (GalgalNAc) 0-galactosides
Melibiose-BSA a-galactosides
a-D-glucose (a-D-gluc) a-glucosides
Maltose-BSA
Fucose-BSA a-fucosides
Mannose-BSA x-mannosides
Mannan-BSA
Galactose-BSA galactosides/charged sugars
Sialic acid-BSA (sialic ac) sugars with carboxyl group
Group II
Asialotransferrin (ATF)
Lactose-BSA a-galactosides
Asialocasein (ASC)
Heparin, fucoidan sulfated polysaccharides
Rhamnose-BSA deoxyhexopyranosides
ised in replicate sections using the chromogenic substrate,
3-3'-diaminobenzidine, in a peroxidase reaction. Matching
serial sections were stained with standard haematoxylin and
eosin procedures.
Microdensitometry and image-analysis
Measurements were made on an Olympus Vanox microscope
fitted with a computer-regulated light source. Transmitted
light was collected in a videcon (silicon) detector (SIT 66 TV
camera: Dage-MTI, Michigan), with a sensitivity of 0.01 lux.
Output from the detector was directed to a microcomputer-
integrated, automatic image analysis system (Southern
Microcomputer Instruments Inc, Atlanta, GA), and also dis-
played on a TV monitor.
On each tissue section examined, under x 600 magnifica-
tion, a minimum of nine individual fields was examined
within morphologically intact regions ofcancers; recognisable
non-cancerous tissues and structures were avoided. Each field
measured approximately 2,800 Lm2, contained approximately
30 cancer cells, and corresponded to 8,809 pixels.
Following electronic image-reversal, pixel-intensity corre-
sponds to peroxidase-staining intensity. As the densities of
cancer cells in tumours in the different anatomic sites were
similar, the pixel/cancer cell ratios were also similar (average:
249 pixels per cell). Determination of cancer cell staining
intensities utilised predetermined threshold values as follows:
(1) Specific intensity thresholds
Group I Neoglycoproteins As shown in Figure 1, on the
basis of visual inspection, pixel-intensities between 0 and 135
units corresponded to tissue gaps and non-stained cells, pixel-
intensities between 136 and 180 units corresponded to cancer
cells with 'low' staining intensities, and those between 181
and 250 units corresponded to cancer cells with 'high' stain-
ing intensities. Although the selection of pixel intensity
ranges were initially made on the basis of visual inspection,
these ranges were subsequently used in all automatic densito-
metric measurements
Group II Neoglycoproteins ABC-peroxidase reactions
involving biotinylated -heparin, -fucoidan, -rhamnose-BSA,
-lactose-BSA, -asialotransferrin (AST) and -asialocasein
(ASC) yielded very high staining intensities, which in the case
of heparin, rhamnose, and fucoidan were associated with
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Figure 1 Microdensitometry intensity thresholds: Pixel-intensity
intervals for tissue gaps and non-stained cells (0- 135), 'low stain-
ing' (136-180), and 'high-staining' (181-250) cells.
dense nuclear staining in addition to cytoplasmic staining.
These intensities exceeded the maximum extinction levels
obtained with the other neoglycoproteins. Therefore, with
these six neoglycoproteins (NGP), the incident illumination
levels were increased, and the intensity thresholds after
image-reversal were redefined: 0 to 75 intensity units for
'low'; 76 to 150 units for 'medium' and 151 to 250 for 'high'
intensity reactions. These results were analysed separately
from those obtained with the other NGPs.
(2) Non-specific intensity thresholds
The intensities of non-specific reactions were determined for
each site, by using non-biotinylated bovine serum albumin, in
place of biotinylated neoglycoprotein-probes. These back-
ground reactions were subtracted from all intensity readings.
The areas occupied by regions of non-specific intensities
were calculated by subtraction of the measured areas of
'high' and 'low' specific intensities from the total integrated
intensity measurements. The areas occupied by stroma and
gaps were determined by image analysis of hematoxylin and
eosin-stained sections using 'erosion' techniques, and these
areas were subtracted from the calculated non-specific inten-
sity areas, to give the areas occupied by cancer cells with no
detectable staining (i.e. 'non-stained'). Non-specific stromal
background and tissue gaps were eliminated by interactive
image analysis. Thus, in each field, the relative areas occu-
pied by three classes of cells ('high' and 'low' intensity and
'non-staining') were determined.
(3) Specificity ofneoglycoprotein-binding
The carbohydrate specificities of the measured reactions were
determined for representative endogenous lectin by blocking
(pre-incubation) or competitive inhibition with corresponding
free saccharides and/or unbiotinylated NGPs. In blocking
experiments, sections were pre-incubated for 60 min with750 F. VIDAL-VANACLOCHA et al.
lOOngmm1l unbiotinylated neoglycoproteins or 0.1-0.25M
free saccharide prior to incubation with biotinylated neogly-
coproteins. In competitive inhibition experiments, sections
were exposed to mixtures of biotinylated NGP and free
saccarides or 100-fold excess of unbiotinylated NGP.
Results
The individual areas ( standard errors) of the three or four
different levels of staining-intensities, for the 17 different
probes, each used on tumours grown in five different sites,
together with their statistical analysis, are not given in detail.
Instead, the results are exemplified and summarised in 'pie'
diagrams (Figures 2 to 6), with commentaries. It may be
noted that for 200 separate measurements of areas of differ-
ent intensity, the median coefficient of variation [(standard
deviation . mean) x 100] was 26% with a range of 0 to 30%.
Tissue gaps and stroma accounted for a mean (± s.e.) of
9.3 ± 1.9% of section area in lung metastases and 15.7 +
1.0% in liver metastases, with other sites having similar or
intermediate values. Detailed numerical data are available
from the authors, on request.
Complete inhibition of ABC-peroxidase reactions were
obtained with the appropriate free sugars or non-biotinylated
NGP's with fucoidan mannose, galNAc, heparin and rham-
nose, and partial (50-75%) inhibition with lactose, fucose
and glcNAc.
Complex patterns of reactivities were observed with the 11
NGPs in Group I with tumours grown in five different sites.
The areas occupied by 'high' and 'low' intensity-staining
cancer cells were ranked and compared using Scheffe's multi-
ple comparison test (Pollard, 1977); different ranks were
significantly different at the 5% level. When no areas of
'high' or 'low' intensities were detectable in all sites with
individual NGPs, no ranking was possible. For example, with
aD-glucose, no 'high' intensity areas were detected in any of
the tumour sections. However, when a tumour at any site
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Figure 2 Comparison among relative staining intensity areas in
tissues from different anatomic sites reacted with heparin.
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Figure 3 Comparison between relative staining intensity areas in
tissues from different anatomic sites reacted with fucoidan.
reacted with an NGP, then all areas in the different sites were
ranked, regardless of whether or not reactivity was detected
in any of them.
Areas of tumours in Group I expressing 'high' endogenous
lectin levels were detected in only eight of 77 cases, and in
seven of these, the tumours were growing in the liver. The
lectins expressed at these 'high' levels were those with speci-
ficities for N-acetylated carbohydrates, a-fucosides and a-
mannosides. Areas of tumours expressing 'low' levels of
endogenous lectins, showed a highly complex pattern, in
which most of the highest ranked areas again occurred, in
tumours growing in the liver, followed by caecal then s.c.
sites. Spleen and lung tumours generally expressed the lowest
levels of endogenous lectins. Significant differences in lectin
expression were detected in at least four sites for all NGPs in
this group.
In the tumour sections reacting with the six NGPs in
Group II, the intensity thresholds were different from those
in Group I. However, as in Group I, a complex pattern of
site-associated differences in areas of endogenous lectin ex-
pression was detected. For all NGPs tested in this group,
staining areas at each intensity level were significantly differ-
ent in at least one site. However, in this series, liver and
caecal tumours were outranked in several staining classes by
lung tumours and even spleen or s.c. tumours. Examples of
these differences are illustrated in Figures 2 and 3, showing
the levels of expression at each site of endogenous lectins
with specificities for the sulfated polysaccharides, heparin and
fucoidan.
Liver and lung metastases showed clear-cut differences in
staining patterns with NGPs from both Groups I and II.
Figure 4 shows examples of these different staining patterns
where staining intensity areas are in general, greater in liver
lesions than lung lesions with lactose, rhamnose and galNAc
(also, but not shown in Figure 4, with aD-Glucose, Galgal-
NAc, melibiose, Gal, GlcNAc and mannose). Areas were
lower in liver than in lung lesions with fucoidan, ASC and
heparin. No significant differences were detectable between
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Figure 4 Comparison between relative staining intensity areas of
liver and lung metastases with nine neoglycoproteins selected to
show greater staining in lung than liver; liver than lung and
similar staining areas.
liver and lung metastases with AST, mannan, maltose and
sialic acid probes. Overall, significant differences between
liver and lung metastases were seen in 28 of 44 individual
intensity-areas with NGPs in Group I, and 16 of 18 areas
with NGPs from Group II.
The liver and lung tumours examined here were of two
types: those developing in animals with primary spleen or
kidney lesions respectively, which are termed 'metastases',
and those directly seeded via portal or tain-vein injections,
which are termed 'colonies'. In the liver, statistically signi-
ficant differences were detected between the areas of 'metas-
tases' and 'colonies' expressing the different classes of
staining-intensity. Thus, as shown in Figure 5, there was
significantly greater expression in liver colonies than metas-
tases with heparin, fucoidan, AST, ASC and GaINAc (also,
but not shown in Figure 5, with fucose, melibiose, mannan,
maltose and galactose); there was greater expression in meta-
stases than colonies with aD-glucose and GalgalNAc. As
shown in Figure 6, significant differences were also observed
between lung colonies and metastases; expression was greater
in colonies with heparin, fucoidan, rhamnose and (not shown
in Figure 6) GlcNAc and GalNAc. Conversely, expression
was greater in lung metastases than colonies with AST and
sialic acid.
Figure 5 Comparison between relative staining areas of liver
metastases and liver colonies with six selected neoglycoproteins.
Figure 6 Comparison between relative staining areas of lung
metastases and lung colonies with six selected neoglycoproteins.
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Discussion
The battery of neoglycoproteins used in these experiments
permits us to construct a multi-marker profile of endogenous
lectin expression by cells derived from the same tumour, but
growing in different anatomic sites. Blocking experiments
with representative neoglycoproteins revealed complete
blocking in five, and partial blocking in three cases, indicat-
ing a considerable level of specificity. As with the mirror
image exogenous plant lectins more commonly used to probe
for metastasis-associated parameters of cancer cell popula-
tions, it is not possible at present to ascribe specific functions
to their receptors. Nevertheless, lectin-carbohydrate inter-
actions in general have provided a useful index of alterations
in glycoconjugates which may be associated with the tumour-
igenic and metastatic behaviour of cancer cells (Kellokompu,
1986; Raz & Lotan, 1987; Dennis & Laferte, 1987; Lang et
al., 1988; Nicolson, 1988; Vavasseur et al., 1990; Gabius et
al., 1989, 1990).
The results of the present investigation support the infer-
ences previously drawn from human autopsy data on cases
with a history of colorectal carcinoma, and transplantation
experiments with colon 26 tumours in mice, both of which
indicated that site-associated changes in metastasis-related
behaviour can occur in cancer cell populations during their
growth in different organs, after their delivery to these ana-
tomic sites. We have now shown that shifts in the profile of
endogenous lectin expression also occur in cancer cell popu-
lations and that these shifts relative to the 'primary' lesions
occur not only in the liver but also the lungs. The fact that
the expression of individual lectins was independently vari-
able, changing in different directions in the two sites, under-
scores the potential biologic significance of these alterations.
Indeed, biochemical analyses have indicated that differences
in endogenous lectins expressed by liver and lung metastases
do occur in xenotransplants of human colonic carcinoma
(Gabius & Engelhardt, 1988).
It is of considerable interest that differences in endogenous
lectin expression were also observed between 'metastases' and
'colonies' of Co26 cells in both the liver (Figure 5) and the
lungs (Figure 6). When mice are given intrasplenic injections
of Co26 cells and then immediately splenectomised, tumours
subsequently appear in the liver; more liver tumours develop
when splenectomy is delayed (Ward & Weiss, 1988; unpub-
lished data). Therefore, in the present experiments some
of the nominal liver 'metastases' are in fact 'colonies', where-
as few if any of the 'colonies' resulting from portal vein
injections are 'metastases'. In spite of the mixed origins,
differences were demonstrable between the nominal liver
'metastases' and 'colonies'. In the case of the lung lesions, the
origins of the 'metastases' and 'colonies' are distinct. These
observations indicate that in addition to site-associated differ-
ences developing in cancer cell populations after delivery,
differences also exist before delivery (Weiss, 1985b), between
circulating cancer cells resulting from spontaneous metastasis
and those originating from direct intravenous injections. As
the intravascular delivery phase of metastasis is similar in
both cases, differences may well be due to population selec-
tion associated with intravasation/invasion by the 'primary'
lesions (Hart, 1979), followed by clonal amplification in the
liver and lungs. However, regardless of underlying mechan-
isms, these results caution against the uncritical use of colon-
isation experiments, for those relating to the whole metastatic
process.
In general, differences in cellular parameters which have
been evaluated as potential markers to distinguish between
normal and malignant cells, and between metastatic and
non-metastatic cells, have usually been resolved as quanti-
tative, rather than qualitative differences. The present studies
on tumours growing in different sites are no exception, and
indicate the necessity for objective quantitation of cancer cell
parameters. The present approach establishes the feasibility
of such quantitative discrimination among differences in mul-
tiple parameters which may be subtle and independently
variable. This type of approach provides a valuable way of
constructing a profile of cancer cell populations, in situ, with
preservation of their topographic relationships to each other
and to normal host cells.
Neoglycoproteins were generous gifts from Dr H.-J. Gabius, Max-
Planck-Institut fur Experimentelle Medizin, Gottingen, Germany.
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